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CASE REPORT
 A Caucasian man in early 80s was seen in 
Gastroenterology Clinic referred from the 
Endocrinology clinic for concerns over the CT-
Abdomen findings, requested for complaint of 
tiredness, fatigue, weight loss of three kilograms, 
microcytic picture with low MCV and Ferritin, 
hypomagnesemia.
 He was approached remotely by the Tertiary 
hospital after his father and another sibling were 
managed for complex renal stones, and genetic 
testing confirmed Multiple Endocrine Neoplasia 
Type-1 (MEN1) in them. Following he underwent 
Parathyroidectomy fifty-five years ago and again 
twenty-five years ago, for hypercalcemia. 
 He has a complex past history of MEN I, 
with heterozygous mutation, Zollinger-Ellison 
Syndrome secondary to Gastrinoma of the 
duodenum diagnosed more than 20 years ago 
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Case Report
Hypertrophic Gastric folds with 
Hypomagnesemia, linking the dots
Mansoor Zafar1, Tila Muhammad2, 
Najam us Saher3, Muhammad Toqeer4
ABSTRACT
A Caucasian man in early 80s was seen in Gastroenterology Clinic, following, referral from the Endocrinology 
Clinic for concerns for CT Abdomen requested for tiredness and weight loss of three kilograms. The 
patient also had microcytic picture with low MCV and Ferritin and hypomagnesemia. The CT suggested 
gross circumferential thickening of the wall of stomach with advice for invasive investigations to further 
characterise the CT findings. The Endoscopy suggested grossly enlarged rugae in the stomach, and enlarged 
gastric polyps. Patient was assured no new sinister abnormality. 
Treatment challenges to consider were to stop acid suppression by prescribing Proton Pump Inhibitors (PPIs) 
which would lead to stomach ulcers, or to continue with PPIs with sequalae of worsening of hypertrophic 
gastric folds, enlarged gastric polyps and hypomagnesemia. It would be necessary to consider risk versus 
benefits in either situation to determine an appropriate treatment plan in the long term. 
With background of Zollinger-Ellison Syndrome and MEN1 with heterozygous mutation with gastrinoma 
of the duodenum, and frailty he was advised to continue with Proton Pump Inhibitors with twice weekly 
correction of Magnesium infusions, and Iron tablets following Multi-disciplinary meeting.
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with no previous abdominal surgery, bilateral 
adrenal adenomas asymptomatic, stable 
psoriasis and, hypertension. Other comorbidities 
include, pulmonary embolism and persistent 
hypomagnesaemia on twice weekly magnesium 
infusions, and Omeprazole 20 mg, three times a 
day for more than forty years, as prescribed by 
the tertiary centre. He was later referred to the 
local district general hospital for periodic follow 
up due to frailty. His family history with one son 
who had tested negative for MEN, and another 
child not willing to get investigated. Non-smoker, 
with Alcohol only socially less than 21 units/ 
week, lives with wife. 
Clinical Examination: Suggested normal scaphoid 
abdomen, with stable phase psoriatic patches 
along both elbows. Pulse 69, BP 170/96, Weight 
66 kg (recent visit) and 69.1 kg (six months ago). It 
was concluded that patient needed further work-
up to clarify CT findings. 
Investigations:
Electrolytes: Serum Magnesium 0.38*, Serum 
Inorganic Phosphate 1.14 mmol/l, Serum Sodium 
129* mmol/l, Serum Potassium 4.9 mmol/l, 
Corrected Calcium 2.56 mmol/l. 
Hormonal Profile: Serum FSH 21.3* IU/L, Serum 
LSH 7.2 IU/L, Plasma Gastrin 224* pmol/l, Plasma 
Vasointestinal Peptide <4, Plasma Pancreatic 
Polypeptide 85 pmol/l, Plasma Chromogranin B 
106 pmol/l, Plasma Chromogranin A 64* pmol/l, 
Serum Parathormone 45 ng/l (15-65), Plasma 
Calcitonin <3, Plasma Glucagon 10 pmol/l, Plasma 
Somatostatin 23 pmol/l, Serum IGF-1 23.4, Serum 
Human Growth Hormone 8.64 ug/l, Serum 
Testosterone 25.46 nmol/l.
Haematinics; Ferritin 33, Folate 9.2, Vitamin 
B12 499, MCV 79.7*, Haemoglobin 126*, Platelet 
Count 178.
CT Abdomen:
• Pancreas compressed/displaced by a grossly 
enlarged gastric chamber which appeared to 
correspond to a circumferential thickening of 
the wall of the stomach of uncertain aetiology. 
• Subtle locules of air noted within the 
periphery of the gastric chamber, of uncertain 
significance with presumption of related to 
air between presumably grossly hypertrophic 
rugae or, much less likely, a concomitant 
longstanding bezoar. (Fig.1, 2).
Oral Gastro-Duodenoscopy: 
• Significant hypertrophy of gastric folds in the 
fundus large gastric polyps. (Fig.3, 4).
Treatment:
• The case was discussed in Gastroenterology 
Multi-Disciplinary Meeting.
• Considering the frailty, it was decided that 
patient need to be managed conservatively 
with PPIs, and periodic twice weekly 24 mmol 
Magnesium infusions.
• His corrected Calcium levels to date have been 
in normal range.
Fig.1: Computerised Tomogram (CT) -Abdomen; 
Coronal view, grossly enlarged Stomach.
Fig.2: Computerised Tomogram. Transverse CT view, 
grossly enlarged stomach, pancreatic atrophy.
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Outcome and Follow up:
Patient was assured of no sinister pathology. 
He was advised periodic clinic review in 
Gastroenterology Clinic, with 24 mmol 
Magnesium infusions on regular basis twice in 
a week, with continuation of Omeprazole 20 mg 
three times a day, and Ferrous Gluconate 210 mg 
once daily. He reported resolution of symptoms 
of tiredness, and happy with the conservative 
management.
DISCUSSION
 Zollinger-Ellison Syndrome is neuro-
endocrine functional tumours predominantly of 
either Pancreatic or Duodenal Origin. Incidence 
remains 0.2-2 per 1000000 annually.1 They are 
associated with increase Gastrin Secretion, 
with associated stomach ulcers, diarrhoea and 
other sequalae. Most patents are diagnosed 
in age group 20 to 50 and most of them are 
Men. Surprisingly 80% of cases are sporadic,2 
however, up to 30% of cases are in association 
with MEN1, as our patient.3 The Pancreatic 
Origin is more likely to metastasize; however, 
duodenal origin runs a relatively benign course, 
with less likelihood of being spread to liver at 
the time of presentation, size usually is < 1 cm 
and usually multiple and more likely to occur in 
the first part of duodenum, as in our patient.2,3 
Rarely, they may arise from stomach, liver, bile 
duct, lymphatic channels along mesentery or 
pancreatic region, ovary, and even more rarely 
in heart, lungs-in association with small cell 
lung cancer.4
 In a patient managed conservatively with PPIs on 
long term basis, for duodenal origin of Zollinger-
Ellison Syndrome, there are multiple side-effects 
reported. The common side effects include: 
Hyponatremia, Clostridium difficile enteritis, and 
Interstitial Nephritis. 
 Komorowski et al have elaborated the 
importance of snare biopsy for surveillance to 
rule out Gastric Cancers.5 Kuiper EJ et al, have 
found more predisposition to Helicobacter pylori 
infection with long term use of PPIs6 and more 
incidence of Atrophic Gastritis and Gastric polyps 
with prolong use of PPIs.7
 The National Institute of Diabetes and Digestive 
and Kidney Disease (NIDDK), gives online info 
for patients, general population and healthcare 
providers towards symptomatology, and 
management of the patients with Zollinger-Ellison 
Syndrome in particular in association with MEN1.8 
National Organisation for Rare Disorders also has 
helpful info available.9 
Learning Points: 
• Understanding of side-effects of long-term use 
of PPIs is important to clinically co-relate, with 
side effects.
Hypertrophic Gastric folds with Hypomagnesemia
Fig.3: OGD; Antral view with hypertrophic
Gastric Folds and Large Gastric Polyps.
Fig.4: OGD; Stomach in Retro flexion. The thickening 
seen on the CT secondary to enlarged folds and huge 
fundic gland polyps secondary to chronic PPI use.
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• Endoscopic viewing is important to clarify 
ambiguity by the scans, to rule out stomach 
cancer.
• There are frail patients with Zollinger-Ellison 
Syndrome, associated with MEN1, that can be 
managed conservatively.
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